Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management
Ibrahim S. Alhomoud(Qassim University), Dave L. Dixon(Virginia Commonwealth University), Roy Brown(Virginia Commonwealth University), Preethi Chandrasekaran(The Ohio State University), Azita H. Talasaz(NewYork–Presbyterian Hospital), Anurag Mehta(Emory University)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
September 1, 2024
Cited by 19
Related Papers
The Role of Obesity in Type 2 Diabetes Mellitus—An Overview
|International Journal of Molecular Sciences|2024|405
Effects of Probiotics on Gut Microbiota: An Overview
|International Journal of Molecular Sciences|2024|312
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
|Journal of the American College of Cardiology|2022|154
The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
|Clinical Epigenetics|2015|110
Cellular and Molecular Mechanisms of Insulin Resistance
|Current Tissue Microenvironment Reports|2024|85